Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Laser Immunotherapy
100%
Immunological Response
100%
Immune Response
63%
Glycated chitosan
45%
Multi-walled Carbon Nanotubes (MWCNTs)
45%
Tumor
36%
Laser Irradiation
36%
Low-dose Cyclophosphamide
18%
Treg
18%
Clinical Trials
9%
Melanoma
9%
Metastatic Cancer
9%
Immunological Stimulation
9%
Tumor-bearing Rats
9%
Pigmented Skin
9%
Regulatory T Cells
9%
Cyclophosphamide
9%
Late-stage Breast Cancer
9%
Surfactant
9%
Immunological Function
9%
980 Nm Laser
9%
Immunoadjuvant
9%
Temperature Distribution
9%
Optical Properties
9%
Radiation Effects
9%
Modified Carbon Nanotubes
9%
Irradiation Time
9%
Immunology and Microbiology
Immunotherapy
100%
Immune Response
63%
Laser
36%
Cyclophosphamide
27%
Regulatory T Cell
27%
Low Drug Dose
18%
Optics
9%
Immunologic Adjuvant
9%
Material Science
Carbon Nanotube
100%
Tumor
83%
Surface Active Agent
16%
T-Cells
16%
Optical Property
16%
Neuroscience
Immunotherapy
100%
Chitosan
45%
Cyclophosphamide
27%
T Cell
9%
Surfactant
9%
Engineering
Temperature Distribution
20%
Medicine and Dentistry
Carbon Nanotube
9%
Surfactant
9%